@Article{chd.12709,
AUTHOR = {Varun Aggarwal, Christopher J. Petit, Andrew C. Glatz, Bryan H. Goldstein, Athar M. Qureshi},
TITLE = {Stenting of the ductus arteriosus for ductal‐dependent pulmonary blood flow—current techniques and procedural considerations},
JOURNAL = {Structural and Congenital Heart Disease},
VOLUME = {14},
YEAR = {2019},
NUMBER = {1},
PAGES = {110--115},
URL = {http://www.techscience.com/schd/v14n1/38742},
ISSN = {3071-1738},
ABSTRACT = {The use of prostaglandin‐E1 immediately after birth and subsequent surgical crea‐
tion of the modified Blalock‐Taussig shunt (BTS) shunt have remarkably improved the 
prognosis and survival of children with congenital heart disease and ductal‐depend‐
ent pulmonary blood flow (PBF). Despite the advancement in surgical techniques, 
bypass strategies, and postoperative management, significant morbidity and mortal‐
ity after BTS still remain. Patent ductus arteriosus stenting has been shown to be as 
an acceptable alternative to BTS placement in select infants with ductal‐dependent 
PBF. Newer procedural techniques and equipment, along with operator experience 
have all contributed to procedural refinement associated with improved outcomes 
over the recent years. In this article, we review the procedural and periprocedural 
details, with an emphasis on recent advances of this procedure.},
DOI = {10.1111/chd.12709}
}